{
    "title": "Cytokinetics to focus on heart disease drug after ALS trial failure",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11924597/Drug-developer-Cytokinetics-stop-late-stage-trial-ALS-treatment.html",
    "date": "2023-03-31",
    "keywords": [
        "drug",
        "heart",
        "latestage",
        "development",
        "khushi",
        "mandowara",
        "study",
        "spending",
        "blum",
        "companys",
        "march",
        "friday",
        "disease",
        "treatment",
        "sclerosis",
        "project",
        "aficamten",
        "jewel",
        "pipeline",
        "analyst",
        "justin",
        "kim",
        "approval",
        "value",
        "driver",
        "company",
        "interest",
        "condition",
        "thickening",
        "arrest",
        "year",
        "research",
        "number",
        "light",
        "program",
        "ceo",
        "robert",
        "day",
        "reldesemtiv",
        "review",
        "panel",
        "effect",
        "placebo",
        "impact",
        "trial",
        "cash",
        "food",
        "administration",
        "month",
        "failure",
        "omecamtiv",
        "mecarbil",
        "backing",
        "safety",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}